According to this study, Global Female Contraceptives market size will reach US$ 22810 million by 2031.

Global Female Contraceptives Market Size and Outlook 2025-31

According to this study, the global Female Contraceptives market size will reach US$ 22810 million by 2031. United States market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Female Contraceptives players cover Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Female Contraceptives Industry Forecast looks at past sales and reviews total world Female Contraceptives sales in 2024, providing a comprehensive analysis by region and market sector of projected Female Contraceptives sales for 2025 through 2031. With Female Contraceptives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Contraceptives industry. This Insight Report provides a comprehensive analysis of the global Female Contraceptives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Female Contraceptives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Female Contraceptives market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Contraceptives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Contraceptives. This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraceptives market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Contraceptive Drugs &nbsp;&nbsp;&nbsp; Contraceptive Devices Segmentation by Application: &nbsp;&nbsp;&nbsp; Personal use &nbsp;&nbsp;&nbsp; Hospital This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; Mayer Laboratories &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Mylan &nbsp;&nbsp;&nbsp; Teva &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Lupin Pharmaceuticals &nbsp;&nbsp;&nbsp; Female Health Company &nbsp;&nbsp;&nbsp; Fuji Latex

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Female Contraceptives Market Size (2020-2031) &nbsp;2.1.2 Female Contraceptives Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Female Contraceptives by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Female Contraceptives Segment by Type &nbsp;2.2.1 Contraceptive Drugs &nbsp;2.2.2 Contraceptive Devices &nbsp;2.3 Female Contraceptives Market Size by Type &nbsp;2.3.1 Female Contraceptives Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Female Contraceptives Market Size Market Share by Type (2020-2025) &nbsp;2.4 Female Contraceptives Segment by Application &nbsp;2.4.1 Personal use &nbsp;2.4.2 Hospital &nbsp;2.5 Female Contraceptives Market Size by Application &nbsp;2.5.1 Female Contraceptives Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Female Contraceptives Market Size Market Share by Application (2020-2025) 3 Female Contraceptives Market Size by Player &nbsp;3.1 Female Contraceptives Market Size Market Share by Player &nbsp;3.1.1 Global Female Contraceptives Revenue by Player (2020-2025) &nbsp;3.1.2 Global Female Contraceptives Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Female Contraceptives Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Female Contraceptives by Region &nbsp;4.1 Female Contraceptives Market Size by Region (2020-2025) &nbsp;4.2 Global Female Contraceptives Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Female Contraceptives Market Size Growth (2020-2025) &nbsp;4.4 APAC Female Contraceptives Market Size Growth (2020-2025) &nbsp;4.5 Europe Female Contraceptives Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Female Contraceptives Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Female Contraceptives Market Size by Country (2020-2025) &nbsp;5.2 Americas Female Contraceptives Market Size by Type (2020-2025) &nbsp;5.3 Americas Female Contraceptives Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Female Contraceptives Market Size by Region (2020-2025) &nbsp;6.2 APAC Female Contraceptives Market Size by Type (2020-2025) &nbsp;6.3 APAC Female Contraceptives Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Female Contraceptives Market Size by Country (2020-2025) &nbsp;7.2 Europe Female Contraceptives Market Size by Type (2020-2025) &nbsp;7.3 Europe Female Contraceptives Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Female Contraceptives by Region (2020-2025) &nbsp;8.2 Middle East & Africa Female Contraceptives Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Female Contraceptives Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Female Contraceptives Market Forecast &nbsp;10.1 Global Female Contraceptives Forecast by Region (2026-2031) &nbsp;10.1.1 Global Female Contraceptives Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Female Contraceptives Forecast &nbsp;10.1.3 APAC Female Contraceptives Forecast &nbsp;10.1.4 Europe Female Contraceptives Forecast &nbsp;10.1.5 Middle East & Africa Female Contraceptives Forecast &nbsp;10.2 Americas Female Contraceptives Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Female Contraceptives Forecast &nbsp;10.2.2 Canada Market Female Contraceptives Forecast &nbsp;10.2.3 Mexico Market Female Contraceptives Forecast &nbsp;10.2.4 Brazil Market Female Contraceptives Forecast &nbsp;10.3 APAC Female Contraceptives Forecast by Region (2026-2031) &nbsp;10.3.1 China Female Contraceptives Market Forecast &nbsp;10.3.2 Japan Market Female Contraceptives Forecast &nbsp;10.3.3 Korea Market Female Contraceptives Forecast &nbsp;10.3.4 Southeast Asia Market Female Contraceptives Forecast &nbsp;10.3.5 India Market Female Contraceptives Forecast &nbsp;10.3.6 Australia Market Female Contraceptives Forecast &nbsp;10.4 Europe Female Contraceptives Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Female Contraceptives Forecast &nbsp;10.4.2 France Market Female Contraceptives Forecast &nbsp;10.4.3 UK Market Female Contraceptives Forecast &nbsp;10.4.4 Italy Market Female Contraceptives Forecast &nbsp;10.4.5 Russia Market Female Contraceptives Forecast &nbsp;10.5 Middle East & Africa Female Contraceptives Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Female Contraceptives Forecast &nbsp;10.5.2 South Africa Market Female Contraceptives Forecast &nbsp;10.5.3 Israel Market Female Contraceptives Forecast &nbsp;10.5.4 Turkey Market Female Contraceptives Forecast &nbsp;10.6 Global Female Contraceptives Forecast by Type (2026-2031) &nbsp;10.7 Global Female Contraceptives Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Female Contraceptives Forecast 11 Key Players Analysis &nbsp;11.1 Bayer &nbsp;11.1.1 Bayer Company Information &nbsp;11.1.2 Bayer Female Contraceptives Product Offered &nbsp;11.1.3 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Bayer Main Business Overview &nbsp;11.1.5 Bayer Latest Developments &nbsp;11.2 Mayer Laboratories &nbsp;11.2.1 Mayer Laboratories Company Information &nbsp;11.2.2 Mayer Laboratories Female Contraceptives Product Offered &nbsp;11.2.3 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Mayer Laboratories Main Business Overview &nbsp;11.2.5 Mayer Laboratories Latest Developments &nbsp;11.3 Pfizer &nbsp;11.3.1 Pfizer Company Information &nbsp;11.3.2 Pfizer Female Contraceptives Product Offered &nbsp;11.3.3 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Pfizer Main Business Overview &nbsp;11.3.5 Pfizer Latest Developments &nbsp;11.4 Mylan &nbsp;11.4.1 Mylan Company Information &nbsp;11.4.2 Mylan Female Contraceptives Product Offered &nbsp;11.4.3 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Mylan Main Business Overview &nbsp;11.4.5 Mylan Latest Developments &nbsp;11.5 Teva &nbsp;11.5.1 Teva Company Information &nbsp;11.5.2 Teva Female Contraceptives Product Offered &nbsp;11.5.3 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Teva Main Business Overview &nbsp;11.5.5 Teva Latest Developments &nbsp;11.6 Merck &nbsp;11.6.1 Merck Company Information &nbsp;11.6.2 Merck Female Contraceptives Product Offered &nbsp;11.6.3 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Merck Main Business Overview &nbsp;11.6.5 Merck Latest Developments &nbsp;11.7 Johnson & Johnson &nbsp;11.7.1 Johnson & Johnson Company Information &nbsp;11.7.2 Johnson & Johnson Female Contraceptives Product Offered &nbsp;11.7.3 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Johnson & Johnson Main Business Overview &nbsp;11.7.5 Johnson & Johnson Latest Developments &nbsp;11.8 Lupin Pharmaceuticals &nbsp;11.8.1 Lupin Pharmaceuticals Company Information &nbsp;11.8.2 Lupin Pharmaceuticals Female Contraceptives Product Offered &nbsp;11.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Lupin Pharmaceuticals Main Business Overview &nbsp;11.8.5 Lupin Pharmaceuticals Latest Developments &nbsp;11.9 Female Health Company &nbsp;11.9.1 Female Health Company Company Information &nbsp;11.9.2 Female Health Company Female Contraceptives Product Offered &nbsp;11.9.3 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Female Health Company Main Business Overview &nbsp;11.9.5 Female Health Company Latest Developments &nbsp;11.10 Fuji Latex &nbsp;11.10.1 Fuji Latex Company Information &nbsp;11.10.2 Fuji Latex Female Contraceptives Product Offered &nbsp;11.10.3 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Fuji Latex Main Business Overview &nbsp;11.10.5 Fuji Latex Latest Developments 12 Research Findings and Conclusion

Report	Global Female Contraceptives Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI22968

Buyer Information

Order Summary